#insulin4all USA
A Letter to Congress
27 Mar 2017, 11:41 a.m. in #insulin4all USA by Zach Toth
I write to you today as a young American with serious concerns for the future of health care in this country, namely with the GOP’s proposed American Health Care Act (AHCA). My health situation forces a more elevated interest in the current health care debate compared to many of my young peers because I have type 1 diabetes. My fellow diabetics and I (who number around 30 million in the US) rely on access to affordable prescriptions and health care for our very survival. When I say my concerns are serious, I am not exaggerating. Read more
Diabetes Debt: 3 Stories
14 Mar 2017, 10:57 a.m. in #insulin4all USA, Global Stories by Elizabeth Pfiester
When I was diagnosed with type 1 diabetes 38 years ago (March of 1979), my insulin cost my parents $10 a vial. Now, my co-pay for my insulin is $40 for the brand my insurance company wants me to use, or $60 for the brand that works better for me. If I choose to use my local pharmacy, and get my supplies for 3 months at a time, I have to pay the full amount of $120 for each Rx. If I use the insurance company and get everything via the mail, I only save $20. Read more
The Cold Cost of American Capitalism
1 Mar 2017, 5:17 p.m. in #insulin4all USA, Global Stories by Charles Murphy
My life is a roller coaster ride of uncertainty. I just want the tools I need to manage my life and to experience a semblance of happiness. Instead, I am squabbling with insurance and pharmaceutical companies to provide the care that I believe is my natural human right. The injustices experienced by type 1 diabetics in this country amount to a form of massacre. Read more
Diabetes and the “American Dream”
20 Feb 2017, 10:31 a.m. in #insulin4all USA, Global Stories by Karyn Wofford
I was diagnosed with type 1 diabetes when I was 12, after my mom noticed I had lost an extreme amount of weight after three days at summer camp. She had my uncle, a type 2 diabetic test my blood sugar, like he had many times before because of my fascination with medical equipment. Except this time, something was wrong. Read more
America is Number 1 - in Diabetes Costs
15 Feb 2017, 10:39 a.m. in #insulin4all USA, Global Stories by James Elliott
Everyone likes being #1, and Americans are no exception. Few Americans will be celebrating that they have the world’s highest out of pocket costs for insulin and other life-saving diabetes supplies. Read more
Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers
30 Jan 2017, 9:15 p.m. in #insulin4all USA, News & Statements by T1International
The law firm Hagens Berman has filed a complaint against Eli Lilly, Novo Nordisk, and Sanofi, the ‘big three’ pharmaceutical companies that hold a near-monopoly on the insulin market. People living with type 1 diabetes will be the plaintiffs in this class action lawsuit, which alleges that Eli Lilly, Novo Nordisk and Sanofi have unjustly inflated their prices. Read more
Eli Lilly and Novo Nordisk: More Empty Promises
19 Dec 2016, 9:01 a.m. in #insulin4all USA, News & Statements by Elizabeth Pfiester
Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more
Pharmadness: Your Chance to be a Pharma Company CEO
12 Dec 2016, 11:21 a.m. in #insulin4all USA, News & Statements by Elizabeth Pfiester
Last month the Missing Medicines campaign, of which T1International is proudly a member, launched a new interactive game to illustrate the problems with the global research and development model. This experience is something that everyone should a few minutes to try. Read more
T1International Statement on ADA Insulin Price Petition
18 Nov 2016, 8:24 a.m. in #insulin4all USA, News & Statements by T1International
It is fantastic to see a large diabetes organization speaking out in this way. However, we feel that the ADA’s language around the call for price transparency does not go far enough. Read more
Interview: Open Insulin
26 Aug 2016, 9:41 a.m. in #insulin4all USA, Interviews by Elizabeth Pfiester
Currently we’re working on a novel method to produce human insulin, which is not patented, and as far as I know is not patentable. There are variations on normal human insulin to make them longer or shorter acting, which involve very small changes to the sequence that codes for human insulin... Read more